Loading Nifty 50, Nifty Bank, and Sensex…
Natco Pharma Limited
NATCOPHARM · Corporate filings
NSE
Natco Pharma Limited
NATCOPHARM · NSE · Healthcare
₹808.80
-0.02%
As of 12 Nov 2026
Natco Pharma Limited (NATCOPHARM) is listed on NSE in the Healthcare sector. It last traded at ₹808.80, down 0.02% on the session. Its 52-week range is ₹773.60 to ₹1,226.80.
Research output is rule-based and informational only. It is not investment advice.
Analytics for NATCOPHARM are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Natco Pharma Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Market activity
Short selling - 3,306 shares
Announcement
Market activity
Short selling - 41,397 shares
Market activity
Short selling - 210 shares
Announcement
Announcement
Insider trading
Announcement
Market activity
Short selling - 300 shares
Announcement
Market activity
Short selling - 23,006 shares
Market activity
Short selling - 20,950 shares
Market activity
Short selling - 11,800 shares
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Rights
Rights 2:21 @ Premium Rs 748/- Rights 2:21 @ Premium Rs 748/-
Ex-date: 01 Oct 2026
Dividend
Interim Dividend - Rs 1.50 Per Share Interim Dividend - Rs 1.50 Per Share
Ex-date: 20 Aug 2026
Dividend
Interim Dividend - Rs 1.50 Per Share Interim Dividend - Rs 1.50 Per Share
Ex-date: 18 Feb 2026
Dividend
Interim Dividend - Rs 1.50 Per Share Interim Dividend - Rs 1.50 Per Share
Ex-date: 20 Nov 2025
Dividend
Interim Dividend - Rs 2 Per Share Interim Dividend - Rs 2 Per Share
Ex-date: 19 Aug 2025
Dividend
Interim Dividend - Rs 1.50 Per Share Interim Dividend - Rs 1.50 Per Share
Ex-date: 18 Feb 2025
Dividend
Interim Dividend - Rs 1.50 Per Share Interim Dividend - Rs 1.50 Per Share
Ex-date: 27 Nov 2024
Other
Annual General Meeting Annual General Meeting
Ex-date: 25 Sep 2024
Dividend
Interim Dividend - Rs 3 Per Share Interim Dividend - Rs 3 Per Share
Ex-date: 23 Aug 2024
Dividend
Interim Dividend - Rs 1.25 Per Share Interim Dividend - Rs 1.25 Per Share
Ex-date: 26 Feb 2024
Dividend
Interim Dividend - Rs 1.25 Per Share Interim Dividend - Rs 1.25 Per Share
Ex-date: 24 Nov 2023
Other
Annual General Meeting Annual General Meeting
Ex-date: 25 Sep 2023
Dividend
Interim Dividend - Rs 7 Per Share Interim Dividend - Rs 7 Per Share
Ex-date: 22 Aug 2023
Dividend
Interim Dividend - Rs 1.25 Per Share Interim Dividend - Rs 1.25 Per Share
Ex-date: 21 Feb 2023
Dividend
Interim Dividend - Re 0.75 Per Share Interim Dividend - Re 0.75 Per Share
Ex-date: 21 Nov 2022
Other
Annual General Meeting Annual General Meeting
Ex-date: 23 Sep 2022
Dividend
Interim Dividend - Rs 3.50 Per Share Interim Dividend - Rs 3.50 Per Share
Ex-date: 19 Aug 2022
Dividend
Interim Dividend - Rs 2 Per Share Interim Dividend - Rs 2 Per Share
Ex-date: 24 Feb 2022
Dividend
Interim Dividend - Rs 0.50 Per Share Interim Dividend - Rs 0.50 Per Share
Ex-date: 23 Nov 2021
Other
Annual General Meeting Annual General Meeting
Ex-date: 23 Sep 2021
Board Meetings
09 Sep 2026
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2026.
14 Aug 2026
Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27
08 Jul 2026
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026.
29 May 2026
Natco Pharma Limited has submitted to the Exchange, the Audited financial results for the quarter and year ended March 31, 2026.
24 Mar 2026
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24, 2026
12 Feb 2026
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2026.